Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 31/5/2020
SIETES contiene 93020 citas

<< anterior 21 a 40 de 44 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JGF, Lip GYH, Coats AJS, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD, on behalf of the Beta-Blockers in Heart Failure Collaborative Group. Efficacy of ß blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 2014;384:2235-43. [Ref.ID 98435]
22. Cita con resumen
Groves T. Big strides in Europe towards clinical trial transparency. BMJ 2014;349:g6276. [Ref.ID 98206]
23. Cita con resumen
The Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014;384:591-8. [Ref.ID 97883]
24. Cita con resumen
Vallance P, Chalmers I. Secure use of individual patient data from clinical trials. Lancet 2013;382:1703-4. [Ref.ID 96309]
25. Cita con resumen
Nelson JC, Delucchi KL, Schneider LS. Moderators of outcome in late-life depression: a patient-level meta-analysis. Am J Psychiatry 2013;170:651-9. [Ref.ID 95640]
26. Cita con resumen
Bower P, Kontopantelis E, Sutton A, Kendrick T, Richards DA, Gilbody S, Knowles S, Cuijpers P, Andersson G, Christensen H, Meyer B, Huibers M, Smit F, van Straten A, Warmerdam L, Barkham M, Bilich L, Lovell K, Liu ET-H. Influence of initial severity of depression on effectiveness of low intensity interventions: meta-analysis of individual patient data. BMJ 2013;346:12. [Ref.ID 95373]
27.Tiene citas relacionadas
Doshi P, Jefferson T. The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer. JAMA Intern Med 2013;173:380-2. [Ref.ID 95096]
28.Tiene citas relacionadas Cita con resumen
Steinbrook R. The European Medicines Agency and the brave new world of access to clinical trial data. JAMA Intern Med 2013;173:373-4. [Ref.ID 95095]
29. Cita con resumen
Horton R. Offline: Falling out with pharma. Lancet 2013;381:358. [Ref.ID 94896]
30. Cita con resumen
31. Cita con resumen
32. Cita con resumen
Kmietowicz Z. GSK backs BMJ's policy to publish only studies with full access to data. BMJ 2012;345:1. [Ref.ID 94034]
33. Cita con resumen
Godlee F. Clinical trial data for all drugs in current use. BMJ 2012;345:7. [Ref.ID 94000]
34. Cita con resumen
Vickers AJ, Cronin AM, Maschino AC, Lewith G, MacPherson H, Foster NE, Sherman KJ, Witt CM, Linde K. Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med 2012;172:1444-53. [Ref.ID 93921]
35. Cita con resumen
Coombes R. GlaxoSmithKline grants researchers access to raw clinical trial data. BMJ 2012;345:2-3. [Ref.ID 93906]
37.Tiene citas relacionadas
Ebrahim S, Casas JP. Statins for all by the age of 50 years?. Lancet 2012;380:545-7. [Ref.ID 93574]
39.Tiene citas relacionadas Cita con resumen
De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW, for the Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med 2012;172:611-21. [Ref.ID 92786]
40. Cita con resumen
Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ 2012;344:14. [Ref.ID 92516]
Seleccionar todas
<< anterior 21 a 40 de 44 siguiente >>